Katherine Vousden

Katherine Vousden, PhD

Head of Large Molecule Research

Katherine Vousden obtained a PhD from the Genetics department at the University of Leicester in 1996. Following a postdoctoral placement at the University of Sheffield, she has spent over 22 years in the biopharmaceutical industry – over 19 years of which in the field of antibody discovery and protein engineering. Her position prior to joining Charles River was as an Associate Director at MedImmune/AstraZeneca, where she managed a multidisciplinary team and led numerous large molecule programs through to candidate nomination. In early 2020 Katherine joined Charles River as a Science Director, to support the growth of large molecule capabilities and partnerships across the Discovery organization. She is currently Head of Large Molecule Research for our South San Francisco Antibody Discovery site.

LinkedIn Profile